FDA approves Afrezza for children and adolescents with diabetes

The FDA has approved technosphere insulin, an inhaled form of human insulin, for children and adolescents aged 6 years and older with type 1 and type 2 diabetes, according to an industry press release. Technosphere insulin (Afrezza, MannKind) is a form of insulin delivered through an inhaler that allows for ultra-rapid absorption in the lungs. According to the press release, the insulin’s rapid